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The role of personality trait variation in psychopathology and its influence on the outcome 
of psychotherapy is a burgeoning field. However, thus far most findings were based 
on controlled clinical trials that may only poorly represent real-world clinical settings 
due to highly selective samples mostly restricted to patients with major depression 
undergoing antidepressive medication. Focusing on personality and psychopathology 
in a representative naturalistic sample of psychotherapy patients is therefore worthwhile. 
Moreover, up to date hardly any confirmatory research has been conducted in this field. 
Strictly confirmatory research implies two major requirements: firstly, specific hypotheses, 
including expected effect sizes and statistical approaches to data analysis, must be 
detailed prior to inspection of the data, and secondly, corresponding protocols have to 
be published online and freely available. Here, we introduce a longitudinal naturalistic 
study aimed at examining, firstly, the prospective impact of baseline personality traits on 
the outcome of psychotherapy over a 6-month observation period; secondly, the stability 
and change in personality traits over time; thirdly, the association between longitudinal 
change in psychopathology and personality; fourthly, the agreement between self-reports 
and informant rating of personality; and fifthly, the predictive validity of personality self-
reports compared to corresponding informant ratings. For it, we comprehensively state 
a priori hypotheses, predict the expected effect sizes and detail the statistical analyses 
that we intend to conduct to test these predictions. Such a stringent confirmatory 
design increases the transparency and objectivity of psychopathological research, which 
is necessary to reduce the rate of false-positive findings and to increase the yield of 
scientific research.
Keywords: psychotherapy, psychopathology, personality, confirmatory research, psychiatric treatment, study 
protocol
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INtroDUctIoN
the Importance of Personality for Public 
Mental Health and Psychotherapy
The global burden of disease attributable to mental disorders 
is tremendous (1), in particular in high-income Western socie-
ties, including Europe and the United States of America (2, 3). 
Targeting modifiable risk factors for severe psychopathology 
has therefore highest priority. Previous research has confirmed 
that maladaptive personality is a crucial prospective risk factor 
for ill-health, all-cause mortality, and social functioning deficits 
(4–7). Meta-analyses have further revealed that personality 
shows a substantial association with subjective well-being (8) 
and relationship satisfaction (9). Interestingly, behavioral genet-
ics suggest that the pleiotropic genetic influences underlying 
personality trait variation fully account for the genetic interin-
dividual differences in subjective well-being (10). Evidence from 
cross-sectional studies suggests that personality traits, in particu-
lar high neuroticism and low conscientiousness, strongly relate 
to psychopathology (11, 12). In longitudinal studies adjusted for 
baseline impairment, the prospective effect of personality traits 
on subsequent occurrence of psychopathology is considerably 
weaker but remains substantial (13–16). Moreover, evidence 
from several quantitative genetic studies suggests that neuroti-
cism and internalizing disorders (i.e., depression, anxiety, and 
stress-related disorders) share approximately 50% of common 
genetic variance (17–19). Recent evidence has further demon-
strated that neuroticism accounts for cognitive traits such as 
rumination and evaluation, which negatively impact on psycho-
pathology (20, 21). In an attempt to quantify the economic costs 
attributable to both neuroticism and common mental disorders 
(i.e., depression, anxiety, and substance-use disorders) in the 
general population, Cuijpers and colleagues (22) found that the 
per capita excess costs for the 25% highest neuroticism scorers 
were approximately 2.5 time higher than the costs attributable to 
all common mental disorders combined. Accordingly, personal-
ity traits are considered among the most important modifiable 
factors influencing public health and psychiatric practice (4, 
23–25). Because of its pervasive and persistent impact on (men-
tal) health and functioning, personality necessarily needs to be 
considered in the planning and conduct of psychotherapy (26, 
27). Indeed, original studies revealed that baseline personality 
significantly interferes with the course of psychopathology and 
the efficacy of psychotherapeutic interventions (28–30). It was 
further demonstrated that personality difficulties take consider-
ably longer to treat than the common number of 15–19 sessions 
routinely administered in randomised controlled trials (RCT) 
(31, 32). In accordance, comorbid personality disorders, which 
can be modeled as maladaptive variants of normal personality 
traits (33–35), have shown to significantly reduce the treatment 
response in patients with mood and anxiety disorders (36–38) 
and to predict long-term functioning deficits and impairments 
(39–42). Taken together, these findings stress the importance 
of personality for public mental health and suggest that 
psychotherapy, which is the second most common treatment 
for mental disorders after psychotropic medication in Europe 
and the United States (43,  44), needs to carefully incorporate 
personality traits.
What this Project Adds to the literature
There are various gaps in the literature that need to be addressed 
to foster and enhance our understanding of personality effects 
on psychopathology over the course of psychotherapeutic 
interventions. So far most original studies on the influence 
of personality on the outcome of psychotherapy have been 
conducted as RCT under laboratory conditions and almost 
exclusively with depressed patients (28–30, 45, 46). Even 
though RCT are considered the gold standard to evaluate the 
efficacy of therapeutic interventions, they have various severe 
limitations, the most important being low external validity and 
poor generalizability (47, 48). That is, real-world effectiveness of 
psychotherapeutic (48) and pharmacological interventions (47) 
is often considerably lower than their efficacy under carefully 
controlled experimental conditions. There are at least two main 
reasons for that discrepancy. Firstly, highly selective inclusion 
criteria in RCT largely exclude participants with complicated 
comorbid disorders and personality pathology as well as 
patients who undergo additional treatments (48). Such a restric-
tive patient enrollment therefore produces biased samples with 
poor external validity that are not representative for the aver-
age patient seen in real-world clinical settings. Secondly, RCT 
are conducted strictly according to psychotherapy treatment 
manuals, while in real-world clinical settings therapists hardly 
consider and adhere to treatment manuals (49). It is therefore 
necessary to examine the association between personality and 
psychopathology in naturalistic real-world setting in order to 
generalize the findings from RCT. Because replication is a cor-
nerstone of good psychological research (50–52), this is a timely 
objective. Moreover, almost all studies on the personality–psy-
chopathology association conducted thus far relied exclusively 
on self-reports, even though self-reports and informant ratings 
of personality traits show only moderate agreement, in par-
ticular with respect to maladaptive neuroticism, pathological 
personality traits, and personality problems (53–55). Because 
both self- and other-reports of personality have incremental 
predictive validity above each other (56–58), the inclusion of 
an informant rating of personality functioning in the predic-
tion of psychopathology and psychotherapy outcomes is thus 
worthwhile. Another important objective of the current project 
is to examine the stability of personality traits over the course 
of 6  months of psychotherapy using a longitudinal pre–post 
design. In community-based epidemiologic studies of person-
ality–psychopathology associations, such a prospective design 
with baseline and follow-up assessment is an established stand-
ard protocol (16, 59–62), but with a few exceptions (61), these 
studies typically assess personality traits at baseline only. As for 
research in clinical samples, various longitudinal studies with 
pre–post assessment of personality traits have focused on the 
stability of personality traits in psychiatric patients (46, 63–65), 
but these chiefly tested the effects of antidepressive medication 
on personality in patients with major depression. There are, in 
addition, some studies focusing on the stability of personality 
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in persons with substance-use problems (61, 66) or psychosis 
(67, 68), but none of these studies specifically examined out-
patients undergoing psychotherapy. Because transdiagnostic 
psychological interventions targeted at modifying neuroticism 
have drawn broad interest in the research community (69, 70), 
focusing on the short-term stability of personality traits in 
unselected psychotherapy users with various diagnoses is thus 
worthwhile.
In sum, research has demonstrated that personality is crucial 
to psychopathology and public mental health (4, 71, 72). Even 
though some clinical psychologists have made compelling cases 
for the inclusion of personality in the planning and conduct of 
psychotherapy (26, 73, 74), the concept of personality remains 
largely underutilized in clinical settings (4, 27). For instance, 
before inception of this project, the psychotherapy institute serv-
ing as the study site that collects the data for the present project, 
did not apply any inventory of normal-range personality such 
as the five-factor model (FFM) of personality (75, 76), and this 
is certainly the rule rather than the exception in psychotherapy 
centers. Treatment protocols targeting neuroticism have been 
developed (69) and are now undergoing systematic evaluation 
(70). However, the treatment and the changeability of personality 
traits in psychotherapy, especially that of maladaptive personal-
ity, remain largely debated (46, 77, 78). The present research 
project thus aims to make several important contributions to 
the literature by applying a stringently objective and transparent 
confirmatory approach.
MAtErIAls AND EQUIPMENt
study site and sampling Procedure
All data will be collected at the Klaus-Grawe-Institute (KGI) 
for psychological therapy in Zurich, Switzerland, which is an 
outpatient psychotherapy center offering psychological therapy 
according to Grawe’s (79) framework of general psychology 
and psychotherapy. That approach aims at the comprehensive 
application of effective and evidence-based techniques of 
various psychotherapeutic orientations, including cognitive, 
behavioral, and interpersonal techniques. Every patient receives 
individually tailored treatment based on his/her individual 
biopsychosocial needs. As a result, each therapy is unique in its 
scope and application of specific psychotherapeutic techniques, 
which precludes the application of restrictive therapy manuals. 
Patients at the KGI present with heterogeneous mental health 
problems, including, but not limited to, depressive disorder, 
panic disorder, generalized anxiety disorder, post-traumatic 
stress disorder, adjustment disorder, acute stress disorder, burn-
out, substance-use disorder, eating disorder, and personality 
disorder. What makes this heterogeneous naturalistic sample so 
valuable is the fact that, in contrast to most RCT (48), inclusion 
is not restricted to specific psychiatric diagnoses. In fact, many 
clients treated at the KGI present with subclinical disorders and 
interpersonal problems and, accordingly, do not meet criteria 
for any diagnosis according to the International Classification 
of Disease 10th Edition (ICD-10) (80), which is in accord with 
the dimensional concept of mental disorders (81–83). In most 
clinical trials reviewed above, these patients would have been 
excluded, which restricts the external validity and generaliz-
ability of findings from such trials.
Collection of data will include all German-speaking patients 
between 18 and 65 years who started psychotherapy at the KGI 
in Zurich dating back to September 2015 when FFM measures 
of personality were included in the standard test battery. Even 
though therapy is also offered to English speaking patients, 
restriction to German-speaking patients was made because 
assessments in English comprise different questionnaires. Data 
from a comprehensive assessment at outset of the psychotherapy 
will be used as baseline measures. After 6  months, all patients 
will be reassessed with a subset of these measures unless their 
therapy ended prior to that. These data will be used as the 
6-month follow-up assessment. Originally, we planned to reas-
sess patients after 12  months (second follow-up), but we now 
came to realize that this is not feasible because there are not 
enough patients who remain incessantly in therapy for so long. 
The 12-month follow-up will therefore not be executed. Based 
on power analyses, we intend to proceed sampling until we have 
approximately n = 100 6-month follow-up assessments. Because 
sample size calculation is intricate and not readily applicable for 
generalised estimating equations (GEE) analysis, we relied on the 
following three sources: firstly, we scrutinized various sample size 
recommendations for correlated data published in the methodo-
logical literature (84–86); secondly, we tested different sample size 
estimations based on repeated measure ANOVA calculated with 
G*Power (87); and thirdly, we considered the significance levels 
for varying effect sizes as obtained from applications of GEE in 
our previous work (14, 88–90). The final sample size of n = 100 
was then estimated based on all these sources for an expected 
moderate effect size (0.3 < d > 0.5), a significance level of α = 0.05 
and power (1 − β) > 0.8.
outline of confirmatory Designs
Psychological research is currently facing a substantial rep-
lication crisis (91), because its main focus lies on publishing 
spectacular positive findings instead of conducting methodo-
logically sound replication studies (52, 92). As a result, many 
researchers involve in questionable research practices, meaning 
that data and statistical models are processed, transformed, 
and modified until one finds the desired association at p < 0.05 
(93, 94). Such inadequate procedures, also referred to as 
p-hacking, often yield irreproducible, inflated, or false-positive 
associations (95–97). To avoid these systematic biases, various 
authors have called for more stringent confirmatory research 
designs (51, 98). To increase the objectivity and transparency 
of research designs, such an approach comprises that concise 
study and analysis protocols are published publicly online. 
These protocols not only define the exact study design, includ-
ing sampling procedure, timing, and conduct of measurements, 
the applied assessment instruments, and the hypotheses to be 
tested but also which outcomes will be analyzed to test these 
predictions. To reduce the flexibility in analysis procedures, 
which markedly inflates the rate of false-positive findings (94), 
one therefore also prespecifies the exact statistical methods and 
how the outcome of interest will be modeled before the data 
are known. According to these state-of-the-art guidelines for 
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confirmatory research (51, 98), we published the original study 
protocol submitted to the KEK publicly online using the Open 
Science Framework (https://osf.io/ukbs5/). The hypotheses 
related to the aims of this project stated in that document will 
be rephrased in more detail below.
Instruments and Measures
Because this is a fully naturalistic study, we will use only instru-
ments and measures that are routinely applied at the KGI to all 
patients. That is, to avoid methodological artifacts such as design 
or experimenter effects, we will not add additional assessment 
procedures that are not part of the basic psychotherapy evalu-
ation. In consequence, the coverage and range of assessment 
instruments is limited those applied at the study site. However, 
note that there are further instruments applied at the KGI 
that are not considered in the present study, because they are 
administered only to selected patients with specific problems or 
because they were considered redundant for the present study 
aims. Normal-range personality will be assessed with a German 
adaptation (99) of the well-established Big Five Inventory (BFI) 
(100). The BFI is a brief self-report inventory capturing the basic 
structure of personality based on the broad domains of neuroti-
cism, extraversion, openness, conscientiousness, and agreeable-
ness. The BFI has been validated in diverse samples across 
nations, including English, German, Dutch, and Chinese, and 
is considered a reliable and valid short assessment of the FFM 
(99–102). Personality will be further assessed using the German 
adaptation (103) of the Inventory of Interpersonal Problems 
(IIP) (104). The IIP relies on the interpersonal circumplex model 
(105, 106) and captures personality difficulties based on the fol-
lowing eight primary domains of interpersonal problems, that 
is, domineering, vindictive, cold, socially avoidant, submissive, 
exploitable, overly nurturant, and intrusive. On a higher-order 
level, these domains collapse into the meta-factors of agency/
dominance and communion/affiliation. The circumplex per-
sonality domains revealed strong and consistent associations 
with both the Big Five traits of extraversion and agreeableness 
and personality disorder dimensions (107–109), which is why 
personality pathology is considered a disorder of interpersonal 
behavior (110–112). In addition to the self-report IIP, an inform-
ant rating scale of the circumplex model will also be administered 
using the Impact Message Inventory-Circumplex (IMI-C) (113, 
114). The informant rating will be provided by various sources; 
however, in most cases, the rater will be the partner/spouse or 
a family member. The BFI will be assessed at both baseline and 
6-month follow-up, while IIP and IMI-C will be completed at 
baseline only due to their length.
Subjective psychopathological symptoms will be assessed with 
the German translation (115) of the Brief Symptom Inventory 
(BSI) (116). The BSI measures psychopathology based on the 
following nine syndromes: somatization, obsessive–compulsive, 
interpersonal sensitivity, depression, anxiety, hostility, phobia, 
paranoia, and psychoticism. Although these scales demonstrated 
good reliability (115, 116), due to rather poor convergent and 
discriminant validity, it has been suggested to use only the total 
impairment score (117). As an alternative measure of subjec-
tive impairment we will use the incongruence questionnaire 
(INK) (118). The INK measures motivational incongruence, 
defined as the discrepancy between a person’s motivational 
goals and his/her perception of the actual fulfilment of his/her 
socio-affective needs. The INK has shown good psychometric 
properties and correlates strongly with psychopathological 
distress, which makes it a valuable tool for treatment evaluation 
in psychotherapy research and practice (118, 119). Finally, the 
treating psychotherapist will quantify the global functioning of 
the patient using the Global Assessment of Functioning (GAF) 
scale (120) in order to obtain an objective other rating of his/her 
psychopathological impairment. All measures of psychopathol-
ogy, that is, BSI, INK, and GAF will be administered both at 
baseline and 6-month follow-up. In addition to the inventories 
and rating scales detailed above, information from the patient 
chart, including diagnoses according to ICD-10, age, sex, and 
education level, will also be recorded in the dataset. The flow-
chart is shown in Figure 1.
stEPWIsE ProcEDUrEs
This observational naturalistic study was approved by the 
Cantonal Ethics Committee of Zurich (KEK) in December 2015 
(reference number 2015-0601). The project is financially sup-
ported by a grant from the OPO Foundation (reference number 
2016-0038) awarded in June 2016 to Dr. Michael P. Hengartner. 
The funder will have no bearing on the conduct, analysis, and 
interpretation of the data and the decision to submit a manuscript 
for publication. As stated above, all German-speaking patients 
starting psychotherapy at KGI in September 2015 and afterward 
will be included in the dataset. At present a total of n = 58 baseline 
and n = 6 follow-up measurements have been completed (effective 
October 2016). To achieve the projected sample size of n = 100 
at 6-month follow-up, data collection will presumably continue 
until autumn 2017. Data analysis and manuscript draft will start 
immediately once the projected sample size has been reached. 
Study results are intended to be published in leading journals of 
clinical psychology, psychopathology, and psychotherapy.
ANtIcIPAtED rEsUlts
Hypotheses and Planned Analyses
Some hypotheses were already roughly defined in winter 2015 
and submitted to the KEK (see https://osf.io/ukbs5/). Here, 
we further detail those predictions and specify the statistical 
analyses that will be applied to test these hypotheses. The con-
firmatory analyses will be divided into two papers. Exploratory 
analyses will be published in additional papers, but these are not 
specified here.
First paper: the first confirmatory analysis will focus on the 
BFI. We will test the following hypotheses:
(1) BFI traits show high differential continuity over time (all 
r > 0.6). To test this prediction, we will compute bivariate 
Pearson correlations between trait scores at baseline and 
6-month follow-up. We will provide both attenuated and 
disattenuated correlation coefficients corrected for scale 
unreliability.
FIgUrE 1 | Participant flowchart. BFI, Big Five Inventory; IIP, Inventory of Interpersonal Problems; IMI-C, Impact Message Inventory-Circumplex; GAF, Global 
Assessment of Functioning; BSI, Brief Symptom Inventory; INK, Incongruence Questionnaire; ICD-10, International Classification of Diseases 10th Edition.
5
Hengartner and Yamanaka-Altenstein Personality, Psychopathology, Psychotherapy: Study Protocol
Frontiers in Psychiatry | www.frontiersin.org February 2017 | Volume 8 | Article 9
(2) BFI traits demonstrate substantial mean-level continu-
ity (all d <  0.5). More specifically, we predict that only 
neuroticism will demonstrate modest mean-level change 
(0.2 <  d >  0.5), while the other four traits will remain 
almost unaltered over time (all d < 0.2). These predictions 
will be tested with t-tests for paired samples by examining 
the differences in standardized mean-level change between 
baseline and 6-month follow-up.
(3) Baseline BFI traits, specifically high neuroticism and 
low conscientiousness, substantially reduce (d >  0.5) the 
effectiveness of psychotherapy based on the BSI, GAF, and 
INK over the 6-month observation period. In order to test 
this prediction, we will compute GEE (121). These statisti-
cal models were introduced to fit regression analyses that 
account for within-subject correlation, which is an inherent 
part of longitudinal studies that rely on repeated outcome 
measures. Together with mixed models and random coef-
ficient models, GEE represent the state of the art for longi-
tudinal data analysis and are preferred to repeated measures 
ANOVA due to their superior psychometric properties 
(122, 123). The baseline BFI traits will be entered as the 
predictor variables and the repeated measures of the BSI, 
GAF, and INK successively as the outcome. The effect size 
of interest will be modeled as the interaction term between 
baseline personality and the time slope coefficient of the 
repeated outcomes, that is, the linear time trend for change 
in BSI, GAF, and INK. By simultaneously adjusting for the 
intercept, such a statistical modeling ensures that change 
in psychopathology over time is estimated independent of 
baseline impairment. These models will be conducted with 
and without adjustment for baseline diagnoses based on 
ICD-10.
(4) Mean-level change in BFI traits is only weakly, if at all, cor-
related with change in psychopathological impairment over 
time (all r < 0.3). To test this hypothesis, we will compute 
individual change scores over time for all repeated measures 
by subtracting the baseline score from the follow-up score. 
The change scores of the BFI traits will then be correlated 
with the change scores of the BSI, GAF, and INK using 
Pearson correlation.
Second paper: the second confirmatory analysis will focus on 
the IIP and IMI-C. We will test the following hypotheses:
(1) Self-reports and informant ratings of interpersonal person-
ality problems are only modestly correlated (all r < 0.3). To 
test this hypothesis, we will subject the IIP (self-report) and 
the IMI-C (informant rating) to a bivariate Pearson correla-
tion analysis.
(2) Both self-reported and informant-rated baseline personal-
ity problems according to the IIP and IMI-C substantially 
reduce (d > 0.5) the effectiveness of psychotherapy according 
to change in BSI, GAF, and INK from baseline to 6-month 
follow-up. As specified above with respect to the BFI, we will 
test these predictions by focusing on the interaction effect 
between baseline personality measures and the time slope 
coefficients of the psychopathology outcomes using a series 
of GEE analyses.
(3) Self-other agreement in personality profiles relates stronger 
to the outcome of psychotherapy than either self-report 
(IIP) or informant rating (IMI-C). To test this hypothesis, 
we will first compute the index of profile agreement (Ipa) 
between IIP and IMI-C as recommended by McCrae (124) 
and then compare the slope-interaction effect of the Ipa 
with the multivariable effects obtained for the IIP and the 
IMI-C domains based on the results of GEE as specified 
above. The difference between two effect sizes will be 
considered statistically significant if the 95% confidence 
intervals of their standardized regression coefficients do not 
overlap.
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(4) IIP and IMI-C have substantial incremental criterion valid-
ity (ΔR2 > 0.05) above and beyond each other in the predic-
tion of the outcome of psychotherapy. This hypothesis will 
be tested by subjecting the change scores over time for BSI, 
GAF, and INK to a hierarchical linear regression analysis, 
where baseline IIP and IMI-C are entered in interchange-
able hierarchical blocks as the predictor variables. In these 
models, the effect size of interest will be the amount of 
additional variance explained (ΔR2) accounted for by either 
IIP or IMI-C in the prediction of intraindividual change in 
BSI, GAF, and INK over time.
caveats and Potential Pitfalls
We have stressed that clinical trials in psychotherapy and psy-
chopharmacology commonly have poor external validity, that 
is, the efficacy of treatments for mental disorders as estimated 
in the laboratory under controlled conditions using selective 
samples only poorly corresponds to real-world effectiveness in 
unselected naturalistic samples (47, 48). On the other hand, 
clinical trials have considerably higher internal validity than 
observational studies, which is why they are considered the 
gold standard for the estimation of causal effects. That holds 
particularly true when the main objective is to evaluate the 
efficacy of a given intervention. Observational studies are merely 
correlational, as interventions cannot be randomly assigned 
to participants. Therefore, they do not allow for strict causal 
conclusions, although sophisticated statistical techniques such as 
propensity score matching can approximate the internal validity 
of observational designs to that of randomized experiments 
(125). However, as we are mainly interested in the longitudinal 
covariance between personality and psychopathology and in the 
stability of personality, but not on the efficacy of psychotherapy 
as an intervention per  se, that potential limitation is not at 
issue. That is, we are not interested in testing the efficacy of 
an intervention, but rather in evaluating possible mechanisms 
operating within that particular intervention. We will therefore 
not apply propensity score matching, as we do not compare 
psychotherapy users with untreated patients or other treatment 
modalities. A bias that needs to be addressed in such a study is 
the content overlap between personality and psychopathology, 
in particular that between neuroticism and depression (126), as 
that bias might artificially inflate the association between these 
constructs. To solve that problem, we will apply outcomes such 
as the GAF and the INK that have no content overlap with 
neuroticism. Moreover, we will also use alternative measures 
of personality such as the circumplex model of personality 
problems, which will be assessed based on both self-report and 
informant rating. Finally, though we consider the heterogeneity 
of this representative sample a particular strength, one might 
also argue that we compare apples to oranges. That argument 
holds particularly true with respect to interindividual differences 
in baseline impairment. As detailed above, we will resolve that 
issue by applying statistical models that estimate the change in 
psychopathology over time while holding baseline impairment 
constant. In order to additionally control for distinct baseline 
psychopathology, we will also include a patient’s primary diag-
nosis as a covariate.
sUMMArY AND coNclUsIoN
To increase the yield and validity of psychological research find-
ings, direct replications of postulated associations are essential 
(51, 91). In order to strictly adhere to the tenets of confirmatory 
research (98), we prespecified not only our hypotheses but also 
the exact statistical analyses that we intend to conduct to test these 
a priori predictions. In line with an increasing demand for trans-
parency and objectivity in scientific research (51), we published 
this research program publicly and made the original research 
protocol submitted to the local ethics committee that approved the 
study freely available (https://osf.io/ukbs5/). Most of the hypoth-
eses outlined in this paper were prespecified in autumn 2015 and 
submitted to the responsible ethics committee in December 2015. 
Moreover, as of the writing of this paper (dating October 2016), 
only six follow-up assessments were completed, which precludes 
any prescreening of the data and hypothesizing in hindsight. By 
this means, we ensure that hypotheses and statistical approaches 
are specified before the data are collected and the results are 
known (98). Unfortunately, way too often hypotheses are specified 
after the results are known, and these post hoc analyses are then 
sold as confirmatory research based on a priori hypotheses (127), 
which substantially undermines the validity of research by inflat-
ing the false-positive rate (98). Therefore, we believe that ours is 
among the most stringent and transparent confirmatory research 
programs on the influence of personality on psychopathology 
and the outcome of psychotherapy under development to date. 
This study aims not only at replicating findings from selective 
RCT samples in a representative naturalistic sample; it will also 
address some major gaps in the scientific literature. These include 
for instance the stability of personality traits in a heterogeneous 
naturalistic sample of psychotherapy outpatients with diverse 
mental disorders others than major depression, the predictive 
validity of informant ratings of personality problems and how 
informant ratings of personality compare to corresponding self-
reports. More than 20  years ago, Weisz and colleagues already 
noted that outcome studies conducted in the laboratory bear 
little validity for real-world clinical settings (128), an argument 
that was comprehensively reestablished approximately a decade 
later by Westen and colleagues (48). However, now, more than 
another decade later, almost nothing has changed. Findings on 
personality effects in psychotherapy studies are still largely based 
on highly selective samples under laboratory conditions, which 
is why we actually do not know whether these findings replicate 
in real-world clinical samples. We therefore believe that this 
confirmatory research program conducted in a representative 
naturalistic clinical setting can make a substantial contribution 
to the scientific literature on the pervasive impact of personality 
in the aetiopathology of mental disorders (4, 71) and corroborate 
(or, possibly, disconfirm) the important role of personality in the 
psychological treatment of these mental health problems (27, 74).
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